Calibrate is a year-long structured coaching program where medication is routed through insurance. Different model from cash-pay compounded providers. We rank them #9 at 70/100 — strong on coaching curriculum, weaker for cash-pay cost-sensitive patients.
Score breakdown — 70/100
| Criterion | Max | Calibrate | Notes |
|---|---|---|---|
| 1. Pricing transparency | 25 | 17 | Program fee transparent; total cost depends on insurance. |
| 2. Pharmacy sourcing | 20 | 12 | Insurance routing — pharmacy varies by patient. |
| 3. Clinical oversight | 15 | 13 | Strong clinical model; MD-led. |
| 4. Regulatory clarity | 15 | 13 | Insurance + branded path — standard regulatory framework. |
| 5. Patient experience | 15 | 11 | Strong coaching; year-long structure. |
| 6. Evidence quality | 10 | 4 | Outcome reporting thin in public materials. |
| Total | 100 | 70 | Rubric application as of May 20, 2026. |
Strengths
- Structured year-long obesity-medicine curriculum.
- Coaching layer is the program centerpiece, not an add-on.
- Insurance routing means medication can be branded with insurance coverage.
- Established brand with multi-year track record.
Weaknesses
- Program fee ($138/mo) plus medication copay or full-pay if insurance denies.
- Total cost depends on insurance — variable.
- Less applicable for cash-pay patients with no insurance prospect.
- Coaching-centric model means cancellation is harder mid-program.
Who should pick Calibrate
- Patients with insurance coverage for branded GLP-1 who want a structured program.
- Patients who want behavioral coaching as the centerpiece.
Who should look elsewhere
- Cash-pay patients with no insurance for branded GLP-1.
- Patients who want compounded medication specifically.
- Patients who want flexibility to discontinue any month.
How Calibrate compares with our #1 pick
NexLife outscores Calibrate on our published rubric. The reasons are summarized in our direct comparison: NexLife vs Calibrate. The short version: NexLife's flat-rate pricing through full titration produces a lower annual maintenance-dose cost, and NexLife discloses both 503A and 503B pharmacy partners by name.
Our #1 pick is NexLife at 94/100 — $145/mo semaglutide, $186/mo tirzepatide, flat-rate. See full NexLife review →
Frequently asked
Calibrate vs cash-pay compounded?
Calibrate's model is structured coaching + insurance-routed branded GLP-1; compounded cash-pay (NexLife) is medication + lighter coaching with predictable cost regardless of insurance.
Total annual cost?
Program fee ~$1,656/yr + medication cost (variable with insurance).